Research Article

The Expansion of Myeloid-Derived Suppressor Cells Is Associated with Joint Inflammation in Rheumatic Patients with Arthritis

Table 2

The correlation between clinical variables in patients with rheumatic disease and the proportion of myeloid derived suppressor cells, as well as their subsets.

Correlation AnalysisMDSCM-MDSCG-MDSC
rprprp

Rheumatoid ArthritisAge (years)-0.2550.165-0.2390.195-0.1450.436
Disease Duration (years)0.0070.9720.0520.781-0.0930.621
ESR (mm/h)0.2650.1500.3220.0770.0810.665
CRP (mg/L)0.3790.0360.5940.000-0.0950.611
Total Joint Pain (scores)0.5290.0020.7660.0000.1420.446
Swollen Joint Counts (n)0.3050.0950.3710.0400.1640.379
HAQ (scores)-0.0030.9870.1600.3900.0660.722
DAS28 (scores)0.4810.0060.7490.0000.0470.801
IgM RF (IU/ml)0.1400.4530.2720.1390.0150.936
ACPA (U/ml)0.4750.0070.6680.0000.0001.000

Ankylosing SpondylitisAge (years)-0.1540.506-0.2110.359-0.1420.538
Disease Duration (years)-0.2170.345-0.2140.352-0.3300.144
ESR (mm/h)0.0870.709-0.1450.5290.0460.844
CRP (mg/L)0.4940.0230.8010.0000.0430.854
Total Joint Pain (scores)0.7070.0000.7990.000-0.0650.780
ASDAS (scores)0.5960.0040.9080.0000.0420.858
BASFI (scores)0.2280.3200.2510.273-0.1510.512

OsteoarthritisAge (years)0.0510.8630.0550.852-0.2560.376
Disease Duration (years)0.0730.805-0.0680.817-0.2760.34
ESR (mm/h)0.0370.8990.037$0.900-0.165$0.573
CRP (mg/L)0.8770.0000.746$0.0020.408$0.148
Total Joint Pain (scores)0.8130.0000.8440.0000.3870.171
Swollen Joint Counts (n)0.3300.2500.5900.0260.1860.525

Systemic Lupus Erythematosus With ArthritisAge (years)0.061$0.858-0.4600.1540.234$0.489
Disease Duration (years)0.1330.6970.0780.8200.3570.281
ESR (mm/h)0.1730.6110.3780.252-0.3420.304
CRP (mg/L)0.5550.0770.8550.001-0.3090.355
Total Joint Pain (scores)0.761$0.0070.9340.0000.101$0.768
Swollen Joint Counts (n)0.5510.0790.9180.000-0.2170.522
SLEDAI (scores)0.139$0.6830.1610.6360.607$0.048
ANA (U/ml)-0.184$0.5890.0001.0000.335$0.315
Anti-dsDNA (U/ml)0.203$0.5490.1820.5930.622$0.041
C3 (g/L)0.229$0.497-0.3280.352-0.112$0.743

Systemic Lupus Erythematosus Without ArthritisAge (years)0.0590.847-0.0390.9000.0330.915
Disease Duration (years)-0.1550.613-0.0770.8010.1090.722
ESR (mm/h)0.2520.4050.1630.596-0.0720.816
CRP (mg/L)0.1710.5770.4890.090-0.1490.628
SLEDAI (scores)0.038$0.901-0.196$0.5220.0540.861
ANA (U/ml)0.219$0.471-0.067$0.8280.0960.754
Anti-dsDNA (U/ml)-0.315$0.295-0.244$0.421-0.0770.802
C3 (g/L)-0.433$0.139-0.580$0.038-0.4320.141

GoutAge (years)-0.7700.015-0.6830.042-0.169$0.665
Disease Duration (years)-0.2180.574-0.2000.6060.051$0.897
ESR (mm/h)0.1510.6990.4330.2440.235$0.543
CRP (mg/L)0.7620.0170.8830.0020.8330.005
Total Joint Pain (scores)0.7950.0100.9110.0010.868$0.002
Swollen Joint Counts (n)0.7120.0310.8780.0020.8330.005
SUA (μmol/L)-0.1510.699-0.1830.6370.082$0.833

HyperuricemiaAge (years)0.077$0.833-0.1230.7360.330$0.351
Disease Duration (years)0.0910.8030.0180.9600.0490.894
ESR (mm/h)-0.395$0.259-0.3260.358-0.170$0.640
CRP (mg/L)0.4300.2140.1590.6610.5430.105
SUA (μmol/L)-0.231$0.522-0.2750.4410.213$0.554

Note: ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; HAQ, health assessment questionnaire; DAS28, disease activity score in 28 joints; RF, rheumatoid factor; ACPA, anti-citrullinated protein antibody; ASDAS, ankylosing spondylitis disease activity score; BASFI, bath ankylosing spondylitis functional index; SLEDAI, systemic lupus erythematosus disease activity index; ANA, antinuclear antibody; Anti-dsDNA, anti-double stranded DNA antibody; C3, complement C3; SUA, serum uric acid; MDSC, myeloid derived suppressor cell; M-MDSC, monocytic MDSC; G-MDSC, granulocytic MDSC; Total Joint Pain was assessed on a visual analog scale (0-10 cm); r, all showed by Spearman’s rank correlation coefficient, except when marked with $ (Pearson’s correlation coefficient);. p<0.05, p<0.01, and p<0.001.